推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

NEURO-ONCOLOGY 期刊收藏夹

2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   新锐期刊分区表:   是否OA期刊:   结果排序:
  体验更多LetPub AI科研工具 >>
智能期刊推荐助手

推荐偏好:

 
AI写作痕迹消减工具

 

近期推荐:
全流程投稿协助套餐服务
SCI论文AI润色+人工QC服务
聚合物期刊JPM征稿|IF持续上升 + APC折扣
Springer Nature特刊征稿
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


NEURO-ONCOLOGY期刊基本信息Hello,您是该期刊的第77795位访客


基本信息 登录收藏
期刊名字NEURO-ONCOLOGYNEURO-ONCOLOGY

NEURO-ONCOLOGY
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.9
52人评分
我要评分

声誉
10.0

影响力
8.4

速度
7.1

期刊ISSN1522-8517
安装APP,查看期刊最新消息
iOS版下载安装安卓版下载安装
E-ISSN1523-5866
2025-2026最新影响因子
(数据来源于搜索引擎)
13.1 点击查看影响因子趋势图
实时影响因子 截止2026年5月06日:11.75
2025-2026自引率5.3%点击查看自引率趋势图
五年影响因子16.7
JCI期刊引文指标 2.79
h-index 105
CiteScore
2026年6月最新版
CiteScoreSJRSNIPCiteScore排名
21.105.2493.329
学科分区排名百分位
大类:Medicine
小类:Neurology (clinical)
Q17 / 403
大类:Medicine
小类:Oncology
Q118 / 428
大类:Medicine
小类:Cancer Research
Q114 / 233

期刊简介
Published monthly from January 2010, Neuro-Oncology is the official journal of the Society for Neuro-Oncology. Also affiliated with the Japan Society for Neuro-Oncology and the European Association of Neuro-Oncology it is a truly global journal in the field.

Dedicated to providing superior and rapid publication of information in all areas of neuro-oncology, the journal contains peer-reviewed articles and reviews, symposia on selected topics, published abstracts of annual meetings, and society news and announcements from around the world.
期刊官方网站https://academic.oup.com/neuro-oncology
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/N-O
该期刊中国学者近期发文 - NewMethodological concerns on overfitting in a cerebrospinal fluid metabolomics study of leptomeningeal metastasis
Author: Zeng, Yaqin; Sun, Peng
Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag046


A reply to two letters to the editor of Neuro-Oncology
Author: Yang, Chunhui; Wang, Qi
Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag047


Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR-mutant non-small-cell lung cancer patients with brain metastases: A phase I/II study
Author: Yu, Min; Chen, Caini; Gong, Youling; Tian, Tian; Li, Yanying; Fan, Hua; Zhang, Lizhi; Deng, Wen; Liu, Yongmei; Peng, Feng; Yu, Yang; Xiu, Weigang; Wang, Yongsheng; Zou, Bingwen; Zhang, Xuanwei; Zhong, Liqiang; Liu, Tianqiong; Wang, Xianfeng; Xu, Yong; Zhou, Lin; Lu, You; Huang, Meijuan
Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag036


RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway
Author: Lin, Jiayi; Liang, Lun; Zhu, Xupeng; Liu, Junjie; Lan, Rongfeng; Wang, Zhenning; Zhang, Dan; Wang, Ying; Hu, Xiaoyan; Huang, Shiyu; Qiu, Linhui; Yang, Shilun; Mou, Yonggao; Chang, Junlei; Yu, Min
Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag055


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足NEURO-ONCOLOGY的语言要求,还能让NEURO-ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被NEURO-ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513
出版商Oxford University Press
涉及的研究方向医学-临床神经学
出版国家或地区UNITED STATES
出版语言English
出版周期Quarterly
出版年份1999
年文章数 184点击查看年文章数趋势图
Gold OA文章占比39.62%
研究类文章占比:
文章 ÷(文章 + 综述)
91.30%
WOS期刊JCR分区
2025-2026年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:CLINICAL NEUROLOGYSCIEQ14/296
学科:ONCOLOGYSCIEQ125/333
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:CLINICAL NEUROLOGYSCIEQ17/296
学科:ONCOLOGYSCIEQ118/333
期刊分区表预警名单 2026年03月发布的新锐学术版:不在预警名单中

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
《新锐期刊分区表》
2026年3月发布
点击查看期刊分区表趋势图
大类学科小类学科Top期刊综述期刊
医学 1区1区2区
ONCOLOGY
肿瘤学
3区3区1区
CLINICAL NEUROLOGY
临床神经病学
4区4区1区
N/A
期刊分区表
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学 1区1区3区
CLINICAL NEUROLOGY
临床神经病学
4区3区1区
ONCOLOGY
肿瘤学
4区1区1区
期刊分区表
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区1区
CLINICAL NEUROLOGY
临床神经病学
2区2区1区
ONCOLOGY
肿瘤学
2区2区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1522-8517%5BISSN%5D
平均审稿速度网友分享经验:
一般,3-8周
平均录用比例网友分享经验:
较难
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在NEURO-ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
提交文稿
期刊常用信息链接
同领域相关期刊 NEURO-ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 NEURO-ONCOLOGY期刊分区表趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
NEURO-ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 期刊分区表趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 期刊分区表相关期刊
  • 同类著名期刊名称 h-index CiteScore
    LANCET NEUROLOGY25975.00
    Nature Reviews Neurology12433.10
    Alzheimers & Dementia9413.90
    BRAIN30821.20
    SLEEP MEDICINE REVIEWS12221.10
    STROKE29213.10
    Brain Stimulation6412.80
    NEUROLOGY3319.50
    JOURNAL OF HEADACHE AND PAIN5011.90
    MOVEMENT DISORDERS17412.10
    期刊分区表同大类学科的热搜期刊 浏览次数
    MEDICINE887350
    JOURNAL OF ETHNOPHARMACOLOGY793920
    Frontiers in Immunology732122
    BIOMEDICINE & PHARMACOTHERAPY716996
    BIOMATERIALS708191
    Frontiers in Pharmacology703829
    PHYTOMEDICINE631343
    Frontiers in Oncology611325
    Biomedical Signal Processing and Control587270
    IEEE Journal of Biomedical and Health Informatics586632
  •  

    NEURO-ONCOLOGY NEURO-ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Methodological concerns on overfitting in a cerebrospinal fluid metabolomics study of leptomeningeal metastasis

    Author: Zeng, Yaqin; Sun, Peng
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag046
        DOI
    2.A reply to two letters to the editor of Neuro-Oncology

    Author: Yang, Chunhui; Wang, Qi
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag047
        DOI
    3.Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR-mutant non-small-cell lung cancer patients with brain metastases: A phase I/II study

    Author: Yu, Min; Chen, Caini; Gong, Youling; Tian, Tian; Li, Yanying; Fan, Hua; Zhang, Lizhi; Deng, Wen; Liu, Yongmei; Peng, Feng; Yu, Yang; Xiu, Weigang; Wang, Yongsheng; Zou, Bingwen; Zhang, Xuanwei; Zhong, Liqiang; Liu, Tianqiong; Wang, Xianfeng; Xu, Yong; Zhou, Lin; Lu, You; Huang, Meijuan
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag036
        DOI
    4.RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway

    Author: Lin, Jiayi; Liang, Lun; Zhu, Xupeng; Liu, Junjie; Lan, Rongfeng; Wang, Zhenning; Zhang, Dan; Wang, Ying; Hu, Xiaoyan; Huang, Shiyu; Qiu, Linhui; Yang, Shilun; Mou, Yonggao; Chang, Junlei; Yu, Min
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag055
        PubMed      DOI
    5.Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilities

    Author: Wu, Fan; Yin, Yi-Yun; Wang, Di; Pan, Chang-Qing; Zhai, You; Yu, Ming-Chen; Wang, Zhi-Liang; Fan, Wen-Hua; Zhao, Zheng; Li, Guan-Zhang; Jiang, Tao; Zhang, Wei
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf294
        PubMed      DOI
    6.MBD3 deficiency decommissions the nucleosome remodeling and deacetylase complex and orchestrates the epigenetic regulation of gene expression to suppress neuroblastoma progression

    Author: Chen, Chen; Guo, Bize; Wu, Siyan; Zhu, Qinfang; Shi, Hui; Wang, Jinhu; Shu, Qiang; Tao, Ting
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf297
        DOI
    7.Super-enhancer-driven TCF4 orchestrates neuroblastoma metastasis by sphingolipid-dependent membrane remodeling and ITGB1-FAK activation

    Author: Lou, Enzhe; Jiang, Liling; Zheng, Yueyuan; Zhuo, Ran; Zhou, Huan; Hu, Shiwen; Shi, Chunxia; Zhang, Haichuan; Li, Xinyue; Jiang, Lizhen; Mao, Qiong; Liu, Aochu; Liu, Bingyuan; Fang, Jinxin; Pan, Jian; Shi, Xianping
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag021
        PubMed      DOI
    8.PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization

    Author: Hong, Biao; Su, Dongyuan; Cui, Xiaoteng; Zhao, Jixing; Wang, Qixue; Zhan, Qi; Yang, Eryan; Yang, Shixue; Ju, Jiasheng; Huang, Yanping; Cheng, Chunchao; Ding, Yaqing; Xu, Hanyi; Cui, Longtao; Zhao, Yilin; Zhao, Xun; Liang, Siwen; Liu, Yuhao; Kang, Chunsheng
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noaf253
        PubMed      DOI
    9.Meningioma microenvironment harbors a rich immune landscape that evolves with biological state

    Author: Guo, Xiaopeng; Moynihan, Zachary A.; Driver, Joseph; Patel, Ruchit, V; Bhave, Varun M.; Maury, Eduardo A.; Knelson, Erik H.; Guo, Hong; Lin, Jia-Ren; Coy, Shannon M.; Wang, Anthony; Gupta, Saksham; Hoffman, Samantha E.; Dunn, Ian F.; Dunn, Gavin P.; Petti, Allegra; Choi, Bryan D.; Choudhury, Abrar; Raleigh, David R.; Wei, Kevin; Reardon, David A.; Barbie, David; Lederer, James A.; Santagata, Sandro; Bi, Wenya Linda
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag022
        PubMed      DOI
    10.Methodological considerations for large language model-based symptom extraction in neuro-oncology electronic health records

    Author: Wang, Xindi; Chang, Zhaoxin; Dong, Hao; Mu, Guangjing; Li, Xingang; Han, Mingzhi
    Journal: NEURO-ONCOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1093/neuonc/noag009
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    LANCET70092.40
    MMWR Surveillance Summaries093.20
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
    Nature Reviews Disease Primers4871.30
    World Psychiatry6184.80
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144649.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386165.20
    LANCET70092.40
    NATURE REVIEWS MICROBIOLOGY250124.00
    Nature Reviews Clinical Oncology127126.60
    NATURE REVIEWS DRUG DISCOVERY289159.20
    NEW ENGLAND JOURNAL OF MEDICINE93374.80
    Nature Reviews Materials61110.60
    Signal Transduction and Targeted Therapy081.60
    ANNALS OF ONCOLOGY21069.60
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共51


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2026 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室